// App-Quantinova.ai

2234 : Development of caninized monoclonal antibodies against PD1

Researchers

Presenter

  • Mikolaj Kocikowski

Principal Investigators

  • Katarzyna Dziubek

  • Borek Vojtesek

  • David Argyle

  • Ted Hupp

  • Maciej Parys

Medical Centers

  • International Centre for Cancer Vaccine Sciences, University of Gdansk, Gdansk, Poland

  • RECAMO, Berno, Czech Republic

Locations

  • Poland

  • Czech Republic

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A